STOK EPS Estimates
Stoke Therapeutics, Inc.
$23.26
+$0.76(+3.38%)
40
Overall
50
Value
18
Tech
52
Quality
Market Cap
$1.50B
Volume
1.01M
52W Range
$20.32 - $40.22
Target Price
$46.44
STOK EPS estimates: the consensus estimate for Stoke Therapeutics, Inc.'s current fiscal year is -$3.52 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
STOK EPS Estimates
- EPS estimate, current quarter
- $-0.88
- EPS estimate, next quarter
- $-0.93
- EPS estimate, current year
- $-3.52
- EPS estimate, next year
- $-3.44
- EPS growth, 3-year
- +64.13%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.12 |
| 2024 | $-1.65 |
| 2023 | $-2.38 |
| 2022 | $-2.60 |
| 2021 | $-2.34 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | STOK | $23.26 | +3.4% | 1.01M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Stoke Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW